Skip to main content

Advertisement

Log in

Assessing the role of the gut microbiome in methylmercury demethylation and elimination in humans and gnotobiotic mice

  • Toxicokinetics and Metabolism
  • Published:
Archives of Toxicology Aims and scope Submit manuscript

Abstract

The risk of methylmercury (MeHg) toxicity following ingestion of contaminated foodstuffs (e.g., fish) is directly related to the kinetics of MeHg elimination among individuals. Yet, the factors driving the wide range of inter-individual variability in MeHg elimination within a population are poorly understood. Here, we investigated the relationship between MeHg elimination, gut microbiome demethylation activity, and gut microbiome composition using a coordinated human clinical trial and gnotobiotic mouse modeling approach together with metagenomic sequence analysis. We first observed MeHg elimination half-lives (t1/2) ranging from 28 to 90 days across 27 volunteers. Subsequently, we found that ingestion of a prebiotic induced changes in the gut microbiome and mixed effects (increased, decrease, and no effect) on elimination in these same individuals. Nonetheless, elimination rates were found to correlate with MeHg demethylation activity in cultured stool samples. In mice, attempts to remove the microbiome via generation of germ-free (GF) animals or through antibiotic (Abx) treatment both diminished MeHg demethylation to a similar extent. While both conditions substantially slowed elimination, Abx treatment resulted in significantly slower elimination than the GF condition, indicating an additional role for host-derived factors in supporting elimination. Human fecal microbiomes transplanted to GF mice restored elimination rates to that seen in control mice. Metagenomic sequence analysis of human fecal DNA did not identify genes encoding proteins typically involved in demethylation (e.g., merB, organomercury lyase). However, the abundance of several anaerobic taxa, notably Alistipes onderdonkii, were positively correlated with MeHg elimination. Surprisingly, mono-colonization of GF free mice with A. onderdonkii did not restore MeHg elimination to control levels. Collectively, our findings indicate the human gut microbiome uses a non-conventional pathway of demethylation to increase MeHg elimination that relies on yet to be resolved functions encoded by the gut microbes and the host

Clinical Trial NCT04060212, prospectively registered 10/1/2019.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

Data availability

The datasets generated are available in the NCBI SRA repository, bioproject: PRJNA954827 (web link pending).

References

Download references

Funding

Supported by NIEHS R01 ES030940, P30 ES001247, T32 207026.

Author information

Authors and Affiliations

Authors

Contributions

GLC: Germ-free and gnotobiotic mouse models, Alistipes onderdonkii experiments, mouse model sample processing and MeHg elimination data acquisition, interpretation, materials and methods, results, figures, and editing. INK: Human Trials, human sample processing and MeHg elimination data acquisition, in vitro human fecal cultures, mouse model sample processing and MeHg elimination data acquisition, interpretation, materials and methods, results, figures, and editing. MM-E: Metagenomic sequence analysis, bioinformatics, interpretation, materials and methods, results, figures, and editing. CRB: Human Trials, human MeHg elimination data acquisition, materials and methods, and results. DV: Human Trials and human sample processing. DRC: Bioinformatics and materials and methods. EJB: Co-advisor, experimental design, interpretation, results, introduction, discussion, and editing. STW: Co-advisor, experimental design, interpretation, results, introduction, discussion, and editing. MDR: Co-advisor, experimental design, human Trials, human sample processing interpretation, results, introduction, discussion, and editing.

Corresponding author

Correspondence to Matthew D. Rand.

Ethics declarations

Conflict of interest

The authors declare there are no conflicts of interest.

Ethical standards

All the procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. All human and animal studies included in this study have been reviewed and approved by the appropriate Institutional Review Boards (IRBs) of the respective institutions where the studies were conducted (Human Clinical Trials reviewed by the University of Rochester IRB and registered (NCT04060212) and mouse studies reviewed by the Montana State University IRB). All human volunteers participating in this study have given their informed consent prior to enrolling in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (PDF 624 KB)

Supplementary file2 (XLSX 1403 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Coe, G.L., Krout, I.N., Munro-Ehrlich, M. et al. Assessing the role of the gut microbiome in methylmercury demethylation and elimination in humans and gnotobiotic mice. Arch Toxicol 97, 2399–2418 (2023). https://doi.org/10.1007/s00204-023-03548-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00204-023-03548-7

Keywords

Navigation